Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Chapman

Showing results (31-40 of 320) with videos related to

Pageof 32
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|November 25, 2005
Mechanisms of statin-induced myopathy: a role for the ubiquitin-proteasome pathway?M John Chapman, Alain Carrie
Pharmacological Reviews|September 14, 2006
Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosisAnatol Kontush, M John Chapman
Current Atherosclerosis Reports|April 29, 2010
Lipidomics as a tool for the study of lipoprotein metabolismAnatol Kontush, M John Chapman
Pharmacology & Therapeutics|June 30, 2022
Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acidM John Chapman, R Preston Mason
Pharmacology & Therapeutics|January 25, 2008
Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapyM John Chapman, Andrei C Sposito
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefitAndrei C Sposito, M John Chapman
Circulation|September 5, 2013
Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular diseaseBronwyn A Kingwell, M John Chapman
Journal of the American College of Cardiology|January 22, 2016
Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUSPhilippe Giral, Boris Hansel, John Chapman
The American Journal of Cardiology|July 17, 2007
The pi sign as an indicator of aberrant origin of obtuse marginal coronary arteryAlessandra Brofferio, Jamshid Shirani, John Chapman
Journal of the American College of Cardiology|October 26, 2019
Evolocumab Treatment of Hypercholesterolemia in OSLER-1: Enduring Efficacy, Tolerability, and Safety Over 5 YearsM John Chapman, Henry N Ginsberg
Pageof 32

Showing results (31-40 of 320) with videos related to

Sort By:
Pageof 32
Arteriosclerosis, Thrombosis, and Vascular Biology|November 25, 2005
Mechanisms of statin-induced myopathy: a role for the ubiquitin-proteasome pathway?M John Chapman, Alain Carrie
Pharmacological Reviews|September 14, 2006
Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosisAnatol Kontush, M John Chapman
Current Atherosclerosis Reports|April 29, 2010
Lipidomics as a tool for the study of lipoprotein metabolismAnatol Kontush, M John Chapman
Pharmacology & Therapeutics|June 30, 2022
Cholesterol crystals and atherosclerotic plaque instability: Therapeutic potential of Eicosapentaenoic acidM John Chapman, R Preston Mason
Pharmacology & Therapeutics|January 25, 2008
Hypertension and dyslipidaemia in obesity and insulin resistance: pathophysiology, impact on atherosclerotic disease and pharmacotherapyM John Chapman, Andrei C Sposito
Arteriosclerosis, Thrombosis, and Vascular Biology|October 16, 2002
Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefitAndrei C Sposito, M John Chapman
Circulation|September 5, 2013
Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular diseaseBronwyn A Kingwell, M John Chapman
Journal of the American College of Cardiology|January 22, 2016
Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression After PCI: PRECISE-IVUSPhilippe Giral, Boris Hansel, John Chapman
The American Journal of Cardiology|July 17, 2007
The pi sign as an indicator of aberrant origin of obtuse marginal coronary arteryAlessandra Brofferio, Jamshid Shirani, John Chapman
Journal of the American College of Cardiology|October 26, 2019
Evolocumab Treatment of Hypercholesterolemia in OSLER-1: Enduring Efficacy, Tolerability, and Safety Over 5 YearsM John Chapman, Henry N Ginsberg
Pageof 32